Doctors home in on cause of blood clots potentially linked with Covid-19 vaccines

Doctors say they are homing in on the cause of blood clots that may be linked with certain coronavirus vaccines, and add their findings have important implic...

Posted: Apr 17, 2021 11:10 AM
Updated: Apr 17, 2021 6:00 PM

Doctors say they are homing in on the cause of blood clots that may be linked with certain coronavirus vaccines, and add their findings have important implications for how to treat the condition, regardless of whether vaccines cause it.

Even though the link is not yet firm, they're calling the condition vaccine-induced immune thrombotic thrombocytopenia or VITT. It's characterized by unusual blood clotting combined with a low number of blood-clotting cells called platelets. Patients suffer from dangerous clots and, sometimes, hemorrhaging at the same time.

It's been linked most firmly with the AstraZeneca coronavirus vaccine, which is in wide use in Europe and the UK.

The US Centers for Disease Control and Prevention and the Food and Drug Administration are checking to see if Johnson & Johnson's Janssen vaccine also might cause the blood clots. Both AstraZeneca's vaccine and the J&J vaccine use common cold viruses called adenoviruses as a carrier and some experts suspect the body's response to those viral vectors might underlie the reaction. AstraZeneca's vaccine is not authorized in the US.

The FDA and CDC have asked for a pause in giving out the J&J vaccine while they investigate.

A team led by Dr. Marie Scully, a hematologist at University College London Hospitals, studied 22 patients who developed the syndrome after receiving AstraZeneca's vaccine, and found they had an unusual antibody response. These so-called anti-PF4 antibodies had only been seen before as a rare reaction to the use of the common blood thinner heparin.

The findings support a theory that an immune reaction might underlie the rare blood clots, but the findings don't yet explain it, Scully and colleagues reported in the New England Journal of Medicine Friday. What may be going on is a reaction by the immune system with platelets to cause uncontrolled clotting.

If vaccines cause it, it's still very rare and unusual, they wrote. It might not even be happening any more often in recently vaccinated people than among the population in general.

'The risk of thrombocytopenia and the risk of venous thromboembolism after vaccination against SARS-CoV-2 do not appear to be higher than the background risks in the general population, a finding consistent with the rare and sporadic nature of this syndrome,' they wrote.

'The events reported in this study appear to be rare, and until further analysis is performed, it is difficult to predict who may be affected. The symptoms developed more than five days after the first vaccine dose,' they added.

'In all cases reported to date, this syndrome of thrombocytopenia (low platelet count) and venous thrombosis (blood clot) appears to be triggered by receipt of the first dose of the (AstraZeneca) ChAdOx1 nCoV-19 vaccine. Although there have been a few reports of patients with symptoms consistent with this clinical syndrome after the receipt of other vaccines against SARS-CoV-2, none have yet been confirmed to fulfill the diagnostic criteria,' they added.

But if vaccination can cause the condition, it would be important to recognize that and treat it appropriately -- because the usual treatment for blood clots is not recommended for VITT.

Patients should be given anti-clotting drugs, but not heparin, and infusions of a blood product called intravenous immunoglobulin may replace the depleted platelets.

It's also not clear who's at highest risk, Dr. Douglas Cines of the University of Pennsylvania and Dr. James Bussel of Weill Cornell Medicine wrote in a commentary. 'Most of the patients included in these reports were women younger than 50 years of age, some of whom were receiving estrogen-replacement therapy or oral contraceptives. A remarkably high percentage of the patients had thromboses at unusual sites,' they wrote.

Some European countries have restricted who should get AstraZeneca's vaccine. For example. Belgium limits its use in people under age 55. Other countries have paused its use. CDC's vaccine advisers have been asked to consider whether similar restrictions might be appropriate for Johnson & Johnson's vaccine, although only a handful of cases have been reported in the US.

While blood clots in the brain have received the most attention, patients have also had clots in other large veins and arteries.

These blood clots in the brain -- called cerebral venous sinus thromboses or CVST -- are dramatic on their own, but the clots may be forming elsewhere, also.

Doctors are being advised to run tests if people develop blood clots after having been vaccinated recently against coronavirus, and to not use heparin to treat the clots until VITT has been ruled out.

The condition is very similar to a known development called heparin-induced thrombocytopenia, the American Society of Hematology says new guidance released earlier this week. It's also calling the condition VITT.

ASH published guidance saying normal post-vaccination malaise, headache and fever are not of concern.

'Patients with severe, recurrent, or persistent symptoms, particularly intense headache, abdominal pain, nausea and vomiting, vision changes, shortness of breath, and/or leg pain and swelling, either persisting or beginning four to 20 days following vaccination should be evaluated urgently by a medical provider and consideration given to underlying VITT,' ASH says in the new guidance.

'While current information links VITT to AstraZeneca and Johnson & Johnson vaccines, patients with suggestive timing and symptoms following any COVID-19 vaccine should be evaluated for VITT.'

CDC's Advisory Committee on Immunization Practices has scheduled a meeting for April 23 to take up the question again after declining to make a decision Wednesday. One committee member told CNN more data is needed.

'We need to know what the size of the problem is,' said Dr. Kevin Ault, professor and division director with the University of Kansas Medical Center. 'So we're going to shake the trees in the databases that the CDC has and we also need to know what the denominator is -- is it just young women or the whole population that's been vaccinated?'

CDC wants to know if there is anything specific that might put people at higher risk of developing blood clots after vaccination.

'There are still a fair number of people in the United States who have been vaccinated in the last two weeks,' Ault said. 'We've seen these reactions within two weeks, so it doesn't sound like a very long time, but we'll have a fair amount of data in just those nine or ten days.'

In a letter to the New England Journal of Medicine, scientists at Janssen, the vaccine arm of Johnson & Johnson, say there isn't enough evidence to show the company's Covid-19 vaccine causes the blood clots and they are 'working closely with experts and regulators to assess the data, and we support the open communication of this information to health care professionals and the public.'

'At this time,' they write, 'evidence is insufficient to establish a causal relationship between these events and the Ad26.COV2.S vaccine.'

Vaccines made by Moderna and Pfizer/BioNTech use a different technology that sends genetic material into the body wrapped in lipids, and they have not been linked with blood clots.

Oregon Coronavirus Cases

Data is updated nightly.

Cases: 314841

Reported Deaths: 3624
CountyCasesDeaths
Multnomah51325643
Washington35086277
Marion32748396
Clackamas26680275
Lane24145248
Jackson21050257
Deschutes16703103
Umatilla12736125
Douglas10795188
Linn1051487
Josephine8685169
Yamhill752099
Klamath651892
Polk629171
Malheur485567
Benton463728
Coos420669
Columbia325439
Jefferson315347
Lincoln277930
Union274838
Wasco242339
Crook213639
Clatsop213225
Tillamook182023
Baker176123
Morrow168621
Curry167817
Hood River163435
Harney82319
Grant7848
Lake6988
Wallowa50811
Gilliam1374
Sherman1283
Wheeler651
Unassigned00

California Coronavirus Cases

Data is updated nightly.

Cases: 4651497

Reported Deaths: 68087
CountyCasesDeaths
Los Angeles144634825870
Riverside3583834802
San Diego3502674021
San Bernardino3475745507
Orange3150815355
Sacramento1507202105
Santa Clara1407321841
Kern1362881521
Fresno1361631889
Alameda1164051330
Ventura978991120
San Joaquin975341615
Contra Costa95858924
Stanislaus808921235
Tulare73111896
San Mateo52311607
San Francisco52008605
Monterey49485565
Solano44247312
Santa Barbara43189500
Sonoma39476378
Merced39446536
Placer36612364
Imperial34285755
Kings30179285
San Luis Obispo28351313
Madera21749263
Butte21379231
Shasta20763279
Santa Cruz20176211
Yolo19192239
Marin17127242
El Dorado16037127
Sutter13122153
Napa1228795
Yuba928061
Nevada850185
Humboldt831988
Tehama827784
San Benito709567
Mendocino691176
Lassen637927
Tuolumne616993
Lake605887
Amador493059
Glenn399030
Siskiyou391541
Calaveras342766
Del Norte339034
Colusa291018
Inyo166739
Mono14935
Plumas12406
Mariposa100712
Trinity72610
Modoc6278
Unassigned2120
Sierra1980
Alpine1000
Out of CA00
Medford
Clear
64° wxIcon
Hi: 80° Lo: 52°
Feels Like: 64°
Brookings
Clear
66° wxIcon
Hi: 81° Lo: 53°
Feels Like: 66°
Crater Lake
Clear
64° wxIcon
Hi: 58° Lo: 42°
Feels Like: 64°
Grants Pass
Partly Cloudy
64° wxIcon
Hi: 82° Lo: 50°
Feels Like: 64°
Klamath Falls
Clear
63° wxIcon
Hi: 69° Lo: 49°
Feels Like: 63°
Cooler afternoon temperatures and thin haze return on the first day of fall
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events